EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Betrixaban is a broad anti-virus inhibitor by activating innate immunity

Shiyu Hu, Yang Zhao, Xingyu Chen, Haocheng Wang, Wenjun Hu, Rong Huang, Jian Yang, Chenxi Niu, Xuefei Guo, Fuping You

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1603530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Shiyu Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Nation…. Hauptthemen laut MEDLINE: Immunity, Innate, Antiviral Agents, Pyridines, Virus Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects. BT induces IFN-β production and upregulates interferon-stimulated genes (ISGs), effectively suppressing the replication of multiple viruses, including vesicular stomatitis virus (VSV), herpes simplex virus type 1 (HSV-1), murine hepatitis virus strain A59 (MHV-A59), encephalomyocarditis virus (EMCV), and influenza A virus (IAV). BT’s antiviral activity relies on innate immune activation, with IRF3 playing a key role. The antiviral effect was significantly reduced upon loss of ISGs induction, including Mx1 and Mx2. In vivo , BT treatment markedly induced IFNB1 expression across multiple mouse tissues and significantly inhibited viral replication in VSV-infected wild-type mice, confirming the essential role of innate antiviral immune activation. These findings establish BT as a potent stimulator of the innate immune system, demonstrating broad-spectrum antiviral potential and highlighting its promise as a therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateAntiviral AgentsPyridinesVirus DiseasesVirusesAnimalsVirus ReplicationMiceHerpesvirus 1, HumanInterferon-betaInfluenza A virusMice, Inbred C57BLInterferon Regulatory Factor-3VesiculovirusEncephalomyocarditis virusMurine hepatitis virusHumans

Stichwörter der Autor:innen

BetrixabanFXaVSVbroad-spectrum antiviralinnate immunity

Substanzen

Antiviral AgentsInterferon-betaPyridinesInterferon Regulatory Factor-3

Autor:innen und Institutionen

  • Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Pekin…
  • Department of Orthopedics and Traumatology, Nanchong Hospital of Traditional Chinese Medicine, Nanchong, China.
  • Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China.
  • Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.

Zitieren

APA

Hu, S., Zhao, Y., Chen, X., Wang, H., Hu, W., Huang, R., Yang, J., Niu, C., Guo, X., & You, F. (2025). Betrixaban is a broad anti-virus inhibitor by activating innate immunity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1603530

Vancouver

Hu S, Zhao Y, Chen X, Wang H, Hu W, Huang R, et al. Betrixaban is a broad anti-virus inhibitor by activating innate immunity. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1603530

BibTeX
@article{Hu2025,
  author = {Hu, Shiyu and Zhao, Yang and Chen, Xingyu and Wang, Haocheng and Hu, Wenjun and Huang, Rong and Yang, Jian and Niu, Chenxi and Guo, Xuefei and You, Fuping},
  title = {Betrixaban is a broad anti-virus inhibitor by activating innate immunity},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1603530}
}
Kostenlos starten →